Research highlights opportunity to intervene with adolescents, a group who's particularly vulnerable to addiction and overdose.
An HIV and addiction expert shares his insights into the evolving presence of methamphetamine in the opioid crisis and its implications for curbing substance use disorder.
To tackle the overdose epidemic, focusing on opioid prescriptions alone is not enough. New research shows that we’re missing opportunities to save thousands of lives.
Pharmacy pickup is a significant barrier to naloxone access. A policy allows pharmacists to hand out the drug directly at the point of care.
The author of Unbroken Brain discusses our evolving understanding of addiction — and the implications for how we treat and prevent substance use disorders.
New findings suggest that the understudied medication naltrexone may lead to better short-term outcomes for some pregnant women with OUD and their babies.
Polysubstance use, psychiatric conditions, witnessing an overdose, and a lack of stable housing stand out as risk factors among people age 30 and under.
The increased use of unprescribed and prescribed opioids in the accelerating opioid crisis has not spared pregnant women, and infants exposed to opioids in utero are often the unintended target of substance use disorder. Over the past decade, researchers have seen a five-fold increase in the rate of neonatal opioid withdrawal syndrome (NOWS), in which the baby experiences uncomfortable withdrawal symptoms two to three days after birth.
Social workers and patient navigators play a key role in providing services, reducing stigma, and breaking down barriers to care for parents with substance use disorder.
Seeing a worrisome rise in people using multiple substances, providers call for a renewed focus on the social factors underlying addiction.